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Introduction
Epithelia comprised of one or two cell layers cover and protect 
the organs that they encase. The cells making up epithelia are 
constantly turning over by cell division and apoptosis, yet cell 
death could compromise the barrier function of the epithelium. 
We previously found that epithelia use a process termed “apop-
totic cell extrusion” to remove apoptotic cells from a layer, while 
preserving their barrier function (Rosenblatt et al., 2001). Specifi-
cally, an early apoptotic epithelial cell triggers formation of an 
actin and myosin ring in the live neighboring cells surrounding 
it. Contraction of this ring then squeezes the dying cell out of the 
epithelium. Apoptotic cell extrusion is conserved in all in vivo epi-
thelia we have examined ranging from Drosophila to human.
We previously showed that extrusion depends on a chemi-
cal signal from the apoptotic cells, which activates the Rho path-
way in the neighboring cells (Rosenblatt et al., 2001; Slattum   
et al., 2009). Specifically, addition of early apoptotic cells onto 
an epithelial monolayer induces actin assembly in the live con-
tacted cells. Furthermore, inhibition of Rho in the cells sur-
rounding an apoptotic cell blocks extrusion (Rosenblatt et al., 
2001). We recently determined that Rho activation during extru-
sion requires p115 RhoGEF (Slattum et al., 2009), a protein 
activated downstream of the G12/13 G protein–coupled receptor 
(Holinstat et al., 2003). Thus, a signal on the surface of the 
dying cell triggers p115 RhoGEF to activate Rho-mediated   
actin–myosin assembly and contraction in the live surrounding 
cells to remove the dying cell. However, we did not know the 
identity of the signal produced in early apoptotic cells that acti-
vates apoptotic cell extrusion.
Here, we report that the signal produced by dying cells is 
the bioactive lipid sphingosine-1-phosphate (S1P), which acti-
vates actomyosin contraction in surrounding cells via the S1P2 
receptor. Inhibition of S1P synthesis or extracellular S1P sig-
naling blocks apoptotic cell extrusion. The cells surrounding the 
dying cell require S1P2 to bind S1P and activate formation 
and contraction of the actomyosin-extruding ring in both tissue 
culture and zebrafish epithelia. Together, our data reveal the 
signaling pathway that drives a cell to extrude from an epithe-
lial monolayer.
Results and discussion
Blocking S1P signaling inhibits extrusion of 
apoptotic cells
To characterize the extracellular apoptotic signal that triggers 
formation of the actin–myosin extruding ring, we used a modi-
fied version of our previous “cell addition assay.” In that assay, 
T
o  maintain  an  intact  barrier,  epithelia  eliminate   
dying cells by extrusion. During extrusion, a cell   
destined for apoptosis signals its neighboring cells 
to form and contract a ring of actin and myosin, which 
squeezes the dying cell out of the epithelium. Here, we 
demonstrate that the signal produced by dying cells to 
initiate this process is sphingosine-1-phosphate (S1P). 
Decreasing S1P synthesis by inhibiting sphingosine kinase 
activity or by blocking extracellular S1P access to its 
receptor prevented apoptotic cell extrusion. Extracellular 
S1P activates extrusion by binding the S1P2 receptor in 
the cells neighboring a dying cell, as S1P2 knockdown in 
these cells or its loss in a zebrafish mutant disrupted cell 
extrusion. Because live cells can also be extruded, we pre-
dict that this S1P pathway may also be important for driv-
ing delamination of stem cells during differentiation or 
invasion of cancer cells.
Epithelial cell extrusion requires the sphingosine-1-
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inhibitor of SphKs, all dramatically increased the percentage   
of unextruded apoptotic cells compared with control treatment 
(Fig. 1 F). Inhibition of apoptotic cell extrusion by SKIs was 
dose dependent (Fig. S2, C–E). These results show that extru-
sion of apoptotic cells requires SphK activity, presumably be-
cause it catalyzes S1P synthesis.
To regulate many cellular responses, S1P is exported out 
of cells and binds to its receptors on the same or neighboring cells. 
To test whether extracellular S1P is necessary for apoptotic cell 
extrusion, the MDCK monolayer was treated with UV in the 
presence of an S1P-neutralizing mAb (Visentin et al., 2006; 
O’Brien et al., 2009). Formation of the extrusion ring was inhib-
ited by the anti-S1P mAb, and consequently the apoptotic cell 
failed to extrude and was instead retained in the monolayer (Fig. 2, 
B and C). Additionally, the anti-S1P mAb also blocks actin ac-
cumulation induced by cell fragments (Fig. 2, E and F). These 
results suggest that extracellular S1P is critical for extrusion.
Extrusion requires signaling through the 
S1P2 receptor
We next investigated which of the five known high-affinity cell 
surface S1P receptors (S1P1–5) might mediate extrusion signal-
ing. S1P1–3 are ubiquitously expressed, whereas S1P4 and S1P5 
are expressed mainly in lymphoid cells and neuronal cells, respec-
tively. By RT-PCR we determined that mRNAs from S1P1,2,3&5 
are expressed in MDCK cells and another epithelial cell line, 
human bronchial epithelial (HBE) cells (unpublished data). To 
investigate the involvement of S1P receptors in extrusion, we 
treated an HBE monolayer with UV to induce apoptosis in con-
junction with several antagonists that are specific for different 
S1P receptors, and evaluated extrusion of apoptotic cells. Nei-
ther FTY720-P (up to 10 µM), a functional antagonist of all S1P 
receptors except S1P2 (Brinkmann et al., 2002; Mandala et al., 
2002), nor VPC-23019 (up to 10 µM), an antagonist specific for 
S1P1 and S1P3 (Davis et al., 2005), notably affected extrusion of 
apoptotic cells (Fig. 3 A). In contrast, an S1P2-specific antago-
nist, JTE-013 (Osada et al., 2002), increased the proportion of 
un-extruded apoptotic cells by approximately threefold (Fig. 3 A). 
We obtained similar results with these S1P inhibitors in MDCK 
monolayers (not depicted). These results suggested that S1P 
signaling through S1P2, but not the other S1P receptors, is nec-
essary for cell extrusion.
To confirm the involvement of S1P2 in extrusion and to 
determine which cells require this receptor, we used shRNA to 
silence S1P2 expression in HBE cells. GFP-positive cells were 
FAC-sorted and knockdown of S1P2 was confirmed by quantita-
tive RT-PCR (Fig. 3 B). Knockdown of S1P2 dramatically in-
creased the proportion of nonextruded apoptotic cells, compared 
with control shRNA knockdown cells (Fig. 3, C and D). To con-
trol for off-target effects of hairpins, we used two additional 
shRNA sequences to knock down S1P2 and obtained similar re-
sults (Fig. S3, A and B). To test which cells require S1P2, we 
examined extrusion in monolayers that were mosaically knocked 
down for S1P2. A dying cell with S1P2 knockdown surrounded 
by cells with wild-type (WT) levels of S1P2 extrudes success-
fully (Fig. 3 E, representing nine cases in three independent ex-
periments). By contrast, complete S1P2 knockdown of all cells 
addition of early apoptotic cells, but not late apoptotic cells or 
live cells, to an intact Madin Darby canine kidney (MDCK) epi-
thelial monolayer induced actin assembly in the contacted living 
cells. Necrotic cells likely use the same signal that apoptotic 
cells use to produce an extruding ring in epithelia, as laser-ablated 
or mechanically wounded necrotic cells are extruded identically 
to apoptotic cells (Tamada et al., 2007). Therefore, we added 
necrotic cell fragments, prepared by scraping and needle shear-
ing cells and found that they induced accumulation of actin in the 
contacted monolayer and with the same kinetics (Fig. 1). When 
added to a cell monolayer, 60% of added control cell frag-
ments (green) resulted in actin (red) accumulation in the con-
tacted cells (Fig. 1, A and C). Pre-digestion of the dead cell 
fragments with trypsin did not significantly alter actin accumu-
lation (Fig. 1 C), suggesting that the signal triggering the re-
sponse is not a protein. We then postulated that the signal is a 
bioactive lipid.
Based on the fact that a bioactive lipid within this cell 
fragment should activate Rho-dependent actomyosin assembly 
and contraction during extrusion, we investigated several candi-
date lipids and found that addition of S1P caused actin accumu-
lation when added to monolayers, as in our cell addition assay 
(Fig. S1). Conversely, a total lipid extraction from Escherichia 
coli that did not contain S1P did not elicit the same reaction. 
Based on this experiment, the fact that a precursor to S1P, cer-
amide, is pro-apoptotic (Kolesnick and Hannun, 1999; Hannun 
and Obeid, 2002), and recent findings that S1P is produced in 
apoptotic cells (Kolesnick and Hannun, 1999; Hannun and Obeid, 
2002; Gude et al., 2008; Weigert et al., 2010), we investigated 
whether this lipid is required for extrusion. To directly test if 
S1P is required for the actin reaction in the cell addition assay, 
we used SKI II, a specific, potent noncompetitive inhibitor of 
SphK that blocks conversion of sphingosine to S1P (French   
et al., 2003). Pre-treatment of cells with SKI II before making 
cell fragments significantly inhibited the formation of actin 
cables when added to monolayers (Fig. 1, B and C). SKI V,   
another SphK inhibitor, also reduced the percentage of cell frag-
ments that induce actin accumulations with even stronger effi-
ciency than SKI II (Fig. 1 C and Fig. S2, A and B). Therefore, 
we conclude that SphK is required in dying cells to trigger actin 
accumulation in the live cells they contact.
To test if SphK is required for extrusion of apoptotic cells 
from an MDCK monolayer, we pretreated the monolayer with 
SKI II and induced apoptosis with short-wave UV light. Extru-
sion was evaluated by immunostaining the resulting mono-
layers for active caspase-3 Ab to identify apoptotic cells, Alexa 
Fluor 568–phalloidin to analyze actin-based extruding rings, 
and Hoechst for DNA. Fig. 1 D shows a control extruding apop-
totic cell, focusing only on the dying cell for the caspase-3 and 
DNA (which is fragmented) and in another plane on the actin 
ring, which is around and beneath the dying cell. Treatment 
with SKI II inhibited formation of the actin extrusion ring and 
resulted in holes in the monolayer wherever there were apop-
totic cells (Fig. 1 E). Note that when a cell extrudes, DNA and 
caspase-3 do not exist in the same plane as its neighboring cells, 
whereas all nuclei are in focus when extrusion is blocked. SKI II, 
SKI V, and d,l-threo-dihydrosphingosine (tDHS), a competitive 669 Extrusion requires sphingosine-1-phosphate receptor 2 • Gu et al.
Treating WT 3 d post-fertilization (dpf) zebrafish with apoptotic 
stimuli resulted in extrusion of dying cells (Fig. 3, F and H), 
whereas induction of apoptosis in miles apart (mil) zebrafish, 
which carry a loss-of-function mutation in S1P2 (Kupperman et al., 
2000), resulted in apoptotic cells that do not extrude (Fig. 3, G and I, 
and Videos 1 and 2). Instead, brightly staining active capase-3– 
positive cells remain in the plane of the epidermis with no obvious 
actin ring around or below them. Of 60 apoptotic cells from WT 
zebrafish, 59 extruded and one did not, whereas of 88 apoptotic 
within the monolayer blocked extrusion of dying cells (Fig. 3 D). 
These  results  support  the  conclusion  that  extrusion  requires 
S1P2 in the cells surrounding a dying cell, but not in the apop-
totic cell itself.
Our previous work showed that the zebrafish larval epider-
mis provides an excellent in vivo model system to study extrusion 
(Slattum et al., 2009). To test if S1P2-mediated signaling is also 
required for apoptotic cell extrusion in vivo, we tested if zebra-
fish that have a mutation in S1P2 could extrude epidermal cells. 
Figure 1.  Inhibitors of SphKs block actin assembly and apoptotic cell extrusion. (A and B) Alexa Fluor 488–labeled cell fragments (green) prepared from 
MDCK cells pretreated with DMSO (A) or SKI II (B) were added to an intact MDCK monolayer. Arrows point to added cell fragments. (C) The percentage of 
cell fragments causing actin assembly from three independent experiments; n = 100 cell fragments per experiment and error bars are standard deviations 
(SDs). *, P < 0.05; **, P < 0.01. (D and E) Extrusion in an MDCK monolayer in the presence of DMSO (D) or SKI II (E). Arrows point to active caspase-3– 
positive dying cells in each case. (F) Quantification of nonextruded active caspase-3–positive apoptotic cells with DMSO or SphK inhibitor treatment from 
three independent experiments; n = 100, error bars = SDs. ***, P < 0.001. Bars, 10 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   670
S1P localizes to the extruding apoptotic 
cell and its surrounding epithelial cells
To visualize S1P formation during apoptotic cell extrusion, we 
stained UV-irradiated HBE monolayers with anti-S1P mAb and 
imaged them by confocal microscopy. Fig. 4 shows representa-
tive 3D projections of images of early, middle, and late stages of 
cells from mil zebrafish, none extruded. Addition of JTE-013 to 
WT zebrafish also blocked extrusion of apoptotic epidermal cells 
(Fig. S3 C). Of 20 apoptotic cells from WT zebrafish treated with 
JTE-013, one extruded and the rest did not. These data indicate 
that S1P signaling through the S1P2 is required for extrusion in a 
number of vertebrate epithelia both in vivo and in culture.
Figure 2.  An inhibitory anti-S1P mAb blocks apoptotic cell extrusion. (A and B) Extrusion in an MDCK monolayer treated with short-wave UV to induce 
apoptosis in the presence of a mouse IgG isotype control (A) or 10 µg/ml anti-S1P mAb (B). (C) Quantification of nonextruded apoptotic cells from three 
independent experiments; n = 100 active caspase-3–positive cells where error bars are SDs; **, P < 0.01. (D and E) Alexa Fluor 488–labeled cell frag-
ments (green) prepared from MDCK cells were added to an intact MDCK monolayer in the presence of a mouse IgG isotype control (D) or 10 µg/ml anti-
S1P mAb (E). (F) The percentage of cell fragments causing actin assembly from three independent experiments; n = 100 cell fragments per experiment and 
error bars = SDs. ***, P < 0.001. Bars, 10 µm.671 Extrusion requires sphingosine-1-phosphate receptor 2 • Gu et al.
Figure 3.  Apoptotic cell extrusion requires the S1P2 receptor. (A) HBE cells induced to undergo apoptosis with UV in the presence of DMSO or the in-
dicated S1P receptor antagonists. (B) qRT-PCR confirms shRNA-mediated knockdown of S1P2 in HBE cells. (C) Quantification of nonextruded apoptotic 
cells in HBE monolayers expressing control or S1P2-specific shRNA after UV treatment. (D and E) A dying HBE cell is not extruded by S1P2-silenced cells   
(D, green), but is extruded successfully by normal surrounding cells (E). When S1P2 shRNA is only in the dying cell (E), it extrudes and is in a higher plane 
than the actin ring below it, but is in the same plane when the surrounding cells are knocked down for S1P2 (D). Projections of extruding and nonextruding 
apoptotic cells from WT (F) or mil (G) zebrafish larvae, respectively. (H and I) Cross sections (XZs) of an apoptotic extruding cell (H) and a nonextruding 
cell (I) from WT (H) and mil zebrafish larvae (I), respectively. For all bar graphs, each bar represents the average percentage of nonextruded apoptotic 
cells to total apoptotic cells with each treatment from three independent experiments; n = 100 dying cells per experiment, error bars = SDs. **, P < 0.01; 
***, P < 0.001. Bars, 10 µm.JCB • VOLUME 193 • NUMBER 4 • 2011   672
Figure 4.  Apoptotic cells produce and transmit S1P during extrusion. (A–C) Confocal fluorescence images during early (A), middle (B), and late (C) stages 
of extrusion of apoptotic cells from an HBE monolayer. (D and E) Confocal fluorescence images of blocked apoptotic cell extrusion by SKI II (D) or the 
S1P2 antagonist JTE-013 (E). Each experimental sample was visualized with five (B and C) or three (A, D, and E) consecutive 3D projections (comprising 
2-µm thickness each), as necessary to span the full distance from the most basal to the most apical section (second-to-bottom and top images, respectively). 
Note that total cell height under the different conditions varies: during early extrusion (A) and when extrusion is blocked with SKI II and JTE-013 (D and E), 
the dying cell is not squeezed out of the epithelium and therefore does not inhabit as great an apical-to-basal distance as when the dying cell is extruding   
(B and C). A, B, C, and E were obtained using a confocal microscope (TCS SP5; Leica), whereas D was taken using an inverted microscope (Eclipse 
TE300; Nikon) converted for spinning disc confocal microscopy. A–E represent zoomed-in region (square) from each montage. (D) Inset denoting that 
the unextruded cell in D is apoptotic. Bars, 10 µm.673 Extrusion requires sphingosine-1-phosphate receptor 2 • Gu et al.
out of the epithelium, thereby detaching it from the epithelium 
and underlying matrix. As S1P is known to promote survival 
(Kolesnick and Hannun, 1999; Hannun and Obeid, 2002; Weigert 
et al., 2010), loss of S1P in the extruded cell may help promote 
its death, whereas the increase of S1P in the surrounding cells 
could promote their survival, ensuring that they can extrude the 
dying cell. How S1P is produced and exported outside the cell 
will be important future goals.
Extrusion is critical for maintaining proper epithelial bar-
rier function; therefore, we expect defects in the S1P2 signaling 
pathway may result in diseases associated with poor mucosal 
barriers. Aberrant levels of S1P have been associated with asthma, 
which many believe may initiate from poor barrier function in 
airway epithelia (Gitter et al., 2001; Proksch et al., 2006; Sartor, 
2006; Kim et al., 2009; Swindle et al., 2009; Voelkel and Spiegel, 
2009). Further, aberrant S1P signaling is known to be involved 
in a variety of pathways that could further aggravate asthma, in-
cluding immune cell migration (Matloubian et al., 2004; Gude 
et al., 2008; Weigert et al., 2009), epithelial proliferation (Shida 
et al., 2008), and vasoconstriction (Watterson et al., 2005). S1P2 
knockout  in  mice  also  results  in  defective  epithelial  barrier 
function in the cochlea (Kono et al., 2007). Therefore, the iden-
tification of the S1P2 pathway in controlling extrusion will 
allow us to test if defective extrusion could bring about a variety 
of epithelial barrier diseases in animal models.
On the other hand, extrusion could be activated normally 
during development or inappropriately during cancer progres-
sion. Several reports have shown that cells can extrude without 
dying (Gibson and Perrimon 2005; Shen and Dahmann 2005; 
Monks et al., 2008). Further, neuroblasts delaminate from a neuro-
epithelium in Drosophila embryos by a process that appears 
similar to basal extrusion (Hartenstein et al., 1994). In advanced 
tumors where cell death is blocked or survival signaling is up-
regulated (LoPiccolo et al., 2008; Liu et al., 2009), extrusion 
could enable exit of tumor cells to initiate metastasis. Given that 
SphK1 is considerably increased in multiple types of cancers 
(French et al., 2003; Johnson et al., 2005; Van Brocklyn et al., 
2005) and that S1P is associated with proliferation, survival, 
extrusion, where apoptotic cells are marked by condensed and 
increasingly fragmented nuclei over time while the actin ring 
that surrounds the dying cell gradually constricts inward over 
time. Apoptotic cells from early to late stages of extrusion con-
tained prominent intracellular pools of S1P that existed in gran-
ular puncta. No staining was observed in secondary Ab–only 
treated cells (not depicted). From early to middle stages of ex-
trusion, S1P was distributed along the plasma membrane pre-
dominantly near the actin ring at the basolateral surface (Fig. 4, 
A and B and insets; and Videos 3 and 4). Notably, S1P puncta 
could be seen in the surrounding cells, especially during the 
middle and late stages of extrusion (Fig. 4 C and Video 5). In-
terestingly, 10% of cells extrude basally instead of apically, 
which produce much less S1P than apically extruding cells (not 
depicted). As expected, addition of SKI blocked S1P accumula-
tion in and around dying cells, in addition to blocking extrusion 
(Fig. 4 D and Video 6). We also note that when signaling via the 
S1P2 was blocked with the antagonist JTE-013, high levels of 
S1P accumulated in the dying, unextruded cells but not in sur-
rounding cells (Fig. 4 E and Video 7). Thus, early apoptotic cells 
appear to produce and transmit S1P, which is taken up in neigh-
boring cells via the S1P2 to drive extrusion.
Taken together, our results suggest that S1P produced by 
apoptotic cells binds and activates S1P2 in neighboring cells to 
trigger contraction of an intercellular actin–myosin ring, which 
then squeezes the dying cell out of the monolayer (Fig. 5, see 
schematic). Pharmacological inhibition, mutation, or shRNA 
silencing of the S1P2 receptor significantly increases the fre-
quency of nonextruded apoptotic cells, suggesting that S1P sig-
nals via S1P2 to drive apoptotic cell extrusion.
Based on our data, we propose a model showing how S1P 
triggers apoptotic cell extrusion (Fig. 5). S1P produced within 
the apoptotic cells is transported to the extracellular surface, 
where it binds S1P2 on the surface of the surrounding cells and 
activates Rho, presumably through p115 RhoGEF (Rosenblatt 
et al., 2001; Slattum et al., 2009), to trigger assembly and con-
traction of the actin–myosin extrusion ring at the live–dying cell 
interface. Contraction of the extrusion ring drives the dying cell 
Figure 5.  Model for how S1P triggers extru-
sion. S1P is produced in the dying cell and ex-
ported to neighboring cells. S1P binds to S1P2 
and triggers formation and contraction of an 
actin-and-myosin II extruding ring to squeeze 
the dying cell out.JCB • VOLUME 193 • NUMBER 4 • 2011   674
Apoptotic cells that possessed clearly shrunken nuclei but were not sur-
rounded by a distinguishable actin ring were defined as nonextruded apop-
totic cells. Apoptotic cells that came out of the plane of the monolayer with 
strong actin staining around and/or underneath the cells were defined as ex-
truded cells. Old apoptotic cells with strong caspase-3 staining floating above 
the monolayer that died before we treated monolayers were excluded.
Microscopy
Fluorescence micrographs of fixed, cultured cells were obtained using a 
microscope (DM 6000B; Leica) with an HCX PL Fluotar 63x/1.25 oil lens 
(Leica) and captured using a Micromax charge-coupled device camera 
(Roper Scientific). IP Laboratory software was used to control the camera 
and  to  process  images.  Fluorescence  micrographs  of  zebrafish  larvae 
were obtained using a microscope (model 90i; Nikon) with a 40x PHI lens 
(Nikon) and captured using a charge-coupled device camera (Retiga 2000R; 
Q Imaging). Confocal micrographs were obtained using a microscope 
(TCS SP5; Leica) with a 63x oil lens or an inverted microscope (Eclipse 
TE300; Nikon) converted for spinning disc confocal microscopy (Andor 
Technologies) using a 60x Plan Fluor 0.95 oil lens with an electron-multiplied 
cooled CCD camera 1,000 x 1,000, 8 x 8 mm
2 driven by the IQ software 
(Andor Technologies). We used ImageJ to stack confocal sections into   
Z series that were then color combined and reconstructed into 3D image   
using MetaMsorph (GE Healthcare). For HBE cells stained with anti-S1P, 
we displayed five consecutive projections of 2-µm thickness each using the 
“montage” function on MetaMorph software. All images were processed 
further using ImageJ, Photoshop (Adobe), Illustrator (Adobe), and Quick-
time Pro (Quicktime) software.
RT-PCR
Total RNA was isolated from cultured cells using the RNeasy kit (QIAGEN) 
and reverse-transcribed using the SuperScript III first strand synthesis kit   
(Invitrogen) with random hexamers according to the manufacturer’s guide-
lines.  PCR  detection  of  S1P1–5  was  conducted  as  described  previously 
(Estrada et al., 2008). In brief, PCR amplification of the targeted fragments 
was performed with 30 cycles of denaturation at 95°C (30 s), annealing 
at 58°C (30 s), and extension at 72°C (30 s). PCR primer pairs used were: 
S1P1: sense, 5-GCACCAACCCCATCATTTAC-3, antisense, 5-TTGTCCC-
CTTCGTCTTTCTG-3;  S1P2:  sense,  5-CAAGTTCCACTCGGCAATGT-3, 
antisense, 5-CAGGAGGCTGAAGACAGAGG-3; S1P3: sense, 5-TCAG-
GGAGGGCAGTATGTTC-3, antisense, 5-GAGTAGAGGGGCAGGA-
TGGT-3; S1P4: sense, 5-AGCCTTCTGCCCCTCTACTC-3, antisense, 
5-ATCAGCACCGTCTTCAGCA-3; and S1P5: sense, 5-ACAACTACACC-
GGCAAGCTC-3, antisense, 5-GCCCCGACAGTAGGATGTT-3. Quanti-
tative real-time PCR was performed using a LightCycler480 (Roche) and 
the SYBR Green PCR master mix (SABiosciences). Relative mRNA expres-
sion was quantified using the comparative threshold method with the con-
tent of actin mRNA as internal control.
shRNA-mediated gene silencing of S1P2
We designed sense and antisense hairpin oligonucleotides specific for S1P2 
(shS1P2-1) according to a published work (Estrada et al., 2008). Two ad-
ditional pairs of hairpin oligonucleotides were used to knockdown the S1P2 
receptor. The oligonucleotide sequences were: shS1P2-2: sense, 5-GCGC-
CATTGTGGTGGAAAA-3, antisense, 5-TTTTCCACCACAATGGCGC-3; 
shS1P2-3: sense, 5-GCAAGTTCCACTCGGCAAT-3, antisense: 5-ATTGC-
CGAGTGGAACTTGC-3. The sense and antisense oligonucleotides were 
annealed and cloned into a pLentilox 5.0–based lentiviral vector. Trans-
ducing lentiviral particles carrying the shRNA oligonucleotides were pro-
duced by packaging in 293T cells. Lentiviral particles carrying nonspecific 
shRNA oligonucleotides were used as a control. HBE cells were transduced 
with lentiviral particles for 6 h in the presence of 2 µg/ml polybrene, 
washed, and replaced with fresh medium. Stably transduced cells were 
FAC-sorted based on GFP fluorescence.
Statistics
The statistical analysis was performed using an unpaired t test. Values of   
P < 0.05 were considered significant.
Online supplemental material
Fig. S1 shows that S1P directly induces actin assembly at the apex of an 
MDCK monolayer. Fig. S2 shows that inhibition of actin assembly and 
apoptotic cell extrusion by inhibitors of SphKs is dose dependent. Fig. S3 
shows  that  apoptotic  cell  extrusion  requires  the  signaling  mediated  by 
S1P2. Video 1 shows a tilting 3D projection movie of two apoptotic cells 
that do not extrude from the epidermis of a mil zebrafish embryo. Video 2 
shows the Z planes of an apoptotic cell that extrudes normally from the 
migration, and invasion of cancer cells (Maceyka et al., 2002; 
Spiegel and Milstien, 2003; Radeff-Huang et al., 2004), in-
creased S1P signaling could enable tumors to invade by misreg-
ulating extrusion. Therefore, our work defining the signaling 
that drives extrusion of an epithelial cell from a layer may also 
be important for driving other delamination events crucial to 
developmental differentiation or invasion of tumor cells.
Materials and methods
Cell culture
MDCK  II  cells  were  cultured  in  Dulbecco’s  minimum  essential  medium 
(DMEM) high glucose with 5% FBS and 100 µg/ml penicillin/streptomycin 
(all from Invitrogen) at 5% CO2, 37°C. HBE cells were cultured in MEM 
supplemented with 10% FBS and l-glutamine in a flask coated with human 
fibronectin type I (BD), bovine collagen I (Purecol; Inamed biomaterials), 
and BSA (Invitrogen).
Drug and UV treatment
Cells were treated with 30 µM SKI II (EMD), 4 µM SKI V (Sigma-Aldrich), 
40 µM tDHS (Avanti Polar Lipids, Inc.), 10 µM JTE-013 (Tocris Bioscience), 
10 µM VPC-23019 (Avanti Polar Lipids, Inc.), 10 µM FTY720-P (Echelon 
Biosciences), or 10 µg/ml murine anti-S1P mAb (LPath) for 10 min before 
UV treatment. To induce apoptosis, cultured monolayers were exposed to 
1,200 µJ/cm
2 UV254 irradiation in a UV series II (Spectroline) and incu-
bated for 2 h before fixation.
Cell staining
Cells were fixed with 4% formaldehyde in PBS at 37°C for 20 min, perme-
abilized for 10 min with 0.5% Triton in PBS, blocked with AbDil (PBS with 
0.1% Triton X-100 and 2% BSA) for 10 min, and incubated with primary 
antibody for 1 h. Antibody concentrations used for immunostaining were: 
1:200 rabbit anti-active caspase-3 (BD) and 50 µg/ml anti-S1P mAb (LPath 
Inc.). Alexa Fluor 488 goat anti–rabbit IgG and Alexa Fluor 488 goat 
anti–mouse IgG were used as secondary antibodies to detect active 
caspase-3 and S1P, respectively. Actin was detected with Alexa Fluor 568–
phalloidin (Invitrogen). DNA was detected with 1 µg/ml Hoechst 33342 
(Sigma-Aldrich) or 5 µM DRAQ5 (Axxora).
Zebrafish staining
To induce apoptosis, we treated 3-d-old zebrafish larvae with 1% DMSO 
on ice for 30 min, followed by recovery at 28°C for 10 min. Embryos were 
then fixed in 4% formaldehyde, 0.15% glutaraldehyde, 1 mM MgCl2, 0.2% 
Triton X-100, and 25 mM Pipes, pH 6.9, for 2 h, blocked in 0.25% casein 
overnight. Cells undergoing apoptosis were identified using an anti-activated 
caspase-3 rabbit polyclonal Ab (BD) followed by incubation with Alexa Fluor 
488 anti–rabbit IgG Ab (Invitrogen). Actin was visualized using 0.1 µg/ml 
Alexa Fluor 568–phalloidin (Invitrogen). DNA was visualized using 1 µg/ml 
DAPI (Sigma-Aldrich) or 5 µM DRAQ5 (Enzo Life Sciences).
Addition of dead cell fragments or S1P to monolayers
To make dead cell fragments, MDCK cells were scraped from the culture 
dish and sheared with a 27G1/2 needle seven times. Cell fragments were 
transferred to a microfuge tube and centrifuged for 1 min at 8,000 rpm in a 
microfuge (Eppendorf). Cells were fluorescently labeled by resuspending 
them in 50 µl DMEM containing 40 µg/ml FITC snail Lectin (Invitrogen) for 
5 min and washed three times with 1 ml of DMEM. The labeled cell frag-
ments were then added to confluent MDCK monolayers cultured on glass 
coverslips, and incubated for 90 min. The coverslips were fixed and stained 
with Alexa Fluor 568–phalloidin and Hoechst dye. For drug inhibition in 
the dead cell fragment addition, cells were pretreated for 10 min with SKI 
at concentrations listed above before scraping and needle shearing. For 
S1P mAb addition, cell fragments were added to MDCK monolayers in the 
presence of 10 µg/ml S1P mAb. For the lipid addition experiment, 20 µg/ml 
S1P (Avanti Polar Lipids, Inc.) or total E. coli lipid extraction (Avanti Polar 
Lipids, Inc.) resuspended in DMEM was added to confluent MDCK mono-
layers,  incubated  for  1  h,  and  fixed  and  stained  with  phalloidin  and 
Hoechst dye, as above.
Quantification of cell extrusion
To quantify the ratio of nonextruded apoptotic cells, we counted 100 active 
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